BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 15715603)

  • 1. Tocolytic therapy and clinical experience. Combination therapy.
    Ingemarsson I
    BJOG; 2005 Mar; 112 Suppl 1():89-93. PubMed ID: 15715603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
    Worldwide Atosiban versus Beta-agonists Study Group
    BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
    European Atosiban Study Group
    Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical practice evaluation of combination of atosiban, ritodrine and ketoprofen for inhibiting preterm labor.
    Grignaffini A; Soncini E; Ronzoni E; Lo Cane F; Anfuso S; Nardelli GB
    Minerva Ginecol; 2007 Oct; 59(5):481-9. PubMed ID: 17912174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women.
    Shim JY; Park YW; Yoon BH; Cho YK; Yang JH; Lee Y; Kim A
    BJOG; 2006 Nov; 113(11):1228-34. PubMed ID: 16978233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy.
    Richter ON; Dorn C; van de Vondel P; Ulrich U; Schmolling J
    Arch Gynecol Obstet; 2005 Jun; 272(1):26-30. PubMed ID: 15909190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience of using oxytocin antagonist atosiban in the rescue therapy of preterm labour].
    Tan JP; Chen H; Du BJ; Liu YL; Wang YH; Zhang JP
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):81-4. PubMed ID: 18683742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy prolongation in triplet pregnancies. Oral vs. continuous subcutaneous terbutaline.
    Elliott JP; Bergauer NK; Jacques DL; Coleman SK; Stanziano GJ
    J Reprod Med; 2001 Nov; 46(11):975-82. PubMed ID: 11762154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of premature labor in sheep by a combined treatment of nimesulide, a prostaglandin synthase type 2 inhibitor, and atosiban, an oxytocin receptor antagonist.
    Grigsby PL; Poore KR; Hirst JJ; Jenkin G
    Am J Obstet Gynecol; 2000 Sep; 183(3):649-57. PubMed ID: 10992188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of oral nifedipine versus terbutaline injection in preterm labor.
    Laohapojanart N; Soorapan S; Wacharaprechanont T; Ratanajamit C
    J Med Assoc Thai; 2007 Nov; 90(11):2461-9. PubMed ID: 18181335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.
    de la Torre L; Istwan NB; Desch C; Rhea DJ; Roca L; Stanziano GJ; González-Quintero VH
    Am J Perinatol; 2008 Oct; 25(9):555-60. PubMed ID: 18773381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of preterm labor with the oxytocin antagonist atosiban.
    Goodwin TM; Valenzuela G; Silver H; Hayashi R; Creasy GW; Lane R
    Am J Perinatol; 1996 Apr; 13(3):143-6. PubMed ID: 8688103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery.
    Wenstrom KD; Weiner CP; Merrill D; Niebyl J
    Am J Perinatol; 1997 Feb; 14(2):87-91. PubMed ID: 9259905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development and introduction of anti-oxytocic tocolytics.
    Lamont RF
    BJOG; 2003 Apr; 110 Suppl 20():108-12. PubMed ID: 12763125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Which tocolytic drugs in case of preterm labor?].
    Carbonne B; Tsatsaris V
    J Gynecol Obstet Biol Reprod (Paris); 2002 Nov; 31(7 Suppl):5S96-104. PubMed ID: 12454631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor.
    Landau R; Morales MA; Antonarakis SE; Blouin JL; Smiley RM
    Clin Pharmacol Ther; 2005 Dec; 78(6):656-63. PubMed ID: 16338281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
    Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L
    BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical practice evaluation of atosiban in preterm labour management in six European countries.
    Husslein P; Roura LC; Dudenhausen J; Helmer H; Frydman R; Rizzo N; Schneider D;
    BJOG; 2006 Dec; 113 Suppl 3():105-10. PubMed ID: 17206976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preterm labour management--an evidence--update.
    Piyamongkol W
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S154-7. PubMed ID: 21213513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preterm labour. The present and future of tocolysis.
    Giles W; Bisits A
    Best Pract Res Clin Obstet Gynaecol; 2007 Oct; 21(5):857-68. PubMed ID: 17459777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.